Caco-2 Cell Sheet Partially Laminated with HT29-MTX Cells as a Novel In Vitro Model of Gut Epithelium Drug Permeability.
Caco-2
HT29-MTX
in vitro model
intestinal permeability
partially laminated model
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
18 Sep 2023
18 Sep 2023
Historique:
received:
31
08
2023
revised:
14
09
2023
accepted:
15
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The intestinal epithelial Caco-2 cell monolayer is a well-established in vitro model useful for predicting intestinal drug absorption in humans. Coculture models of Caco-2 and goblet-cell-like HT29-MTX cells have been developed to overcome the lack of a mucus layer; however, those models are much leakier compared to the intestinal epithelium. Here, we developed a partially laminated culture model where HT29-MTX cells were superimposed onto a Caco-2 monolayer to overcome this issue. A morphological study showed that the piled HT29-MTX cells were voluntarily incorporated into the Caco-2 monolayer, and mucus production was confirmed via periodic acid-Schiff and mucin protein 2 staining. Permeability was evaluated in terms of transepithelial electrical resistance (TEER) and the apparent permeability of paracellular markers with different molecular sizes. The partially laminated model maintained the high barrier function of the Caco-2 monolayer, whose permeability appeared adjustable according to the HT29-MTX/Caco-2 cell ratio. In contrast, the coculture models showed abnormally high permeability of those markers, correlated with low TEER. Thus, the partially laminated model enabled in vitro recapitulation of effective mucosal barrier function. Consequently, this novel model may be useful as an in vitro high-throughput evaluation system for enteral mucosal permeability and mucus-penetrating efficiency of drugs and nanocarriers.
Identifiants
pubmed: 37765306
pii: pharmaceutics15092338
doi: 10.3390/pharmaceutics15092338
pmc: PMC10535880
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Science and Technology Agency
ID : JPMJCR12L4
Références
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2685-92
pubmed: 20846917
Int J Food Sci Nutr. 2015;66(6):680-5
pubmed: 26299896
J Pharm Sci. 2002 Mar;91(3):669-79
pubmed: 11920752
Int J Pharm. 2013 Aug 30;453(1):56-64
pubmed: 23727593
Pharm Res. 1995 Mar;12(3):413-20
pubmed: 7617530
J Control Release. 2022 Jan;341:414-430
pubmed: 34871636
Pharm Res. 1997 Dec;14(12):1835-7
pubmed: 9453077
Cell Tissue Kinet. 1976 Jan;9(1):65-75
pubmed: 1260831
Inflamm Res. 2003 Jun;52(6):258-62
pubmed: 12835897
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12334-6
pubmed: 11675485
Adv Drug Deliv Rev. 2021 Nov;178:113993
pubmed: 34619286
BMC Biol. 2018 Feb 01;16(1):19
pubmed: 29391007
PLoS One. 2013;8(2):e57136
pubmed: 23483881
J Drug Target. 2005 Jan;13(1):29-38
pubmed: 15848952
Adv Drug Deliv Rev. 2009 Feb 27;61(2):75-85
pubmed: 19135107
J Cell Biol. 1989 Apr;108(4):1187-94
pubmed: 2647764
BMC Gastroenterol. 2014 Nov 18;14:189
pubmed: 25407511
PLoS One. 2014 Feb 26;9(2):e89943
pubmed: 24587140
Cells. 2023 Apr 27;12(9):
pubmed: 37174669
Pharm Res. 1993 Jan;10(1):113-8
pubmed: 8430047
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):136-43
pubmed: 25622791
J Pharm Sci. 2000 Jan;89(1):63-75
pubmed: 10664539
PLoS One. 2013 Jul 15;8(7):e68761
pubmed: 23869232
Cell Immunol. 2003 Jan;221(1):42-9
pubmed: 12742381
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):352-61
pubmed: 23478383
Scand J Gastroenterol. 2015 Jan;50(1):3-12
pubmed: 25523551
Pharm Res. 1990 Sep;7(9):902-10
pubmed: 2235888
Am J Physiol Gastrointest Liver Physiol. 2013 Sep 1;305(5):G357-63
pubmed: 23832516
Cell Biol Toxicol. 2005 Jan;21(1):1-26
pubmed: 15868485
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):395-411
pubmed: 18433344
Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G922-9
pubmed: 11292601
J Biomol Screen. 2007 Feb;12(1):84-91
pubmed: 17099244
J Pharmacol Toxicol Methods. 2010 May-Jun;61(3):334-42
pubmed: 20159047
J Cell Biol. 1991 Dec;115(5):1409-18
pubmed: 1955481
Pharm Res. 1995 May;12(5):693-9
pubmed: 7479555
Chemosphere. 2020 Oct 1;:128497
pubmed: 34756374
Int J Pharm. 2018 Mar 1;538(1-2):159-166
pubmed: 29339247
Eur J Pharm Biopharm. 2014 Jul;87(2):290-8
pubmed: 24704198
Pharm Res. 2001 Aug;18(8):1138-45
pubmed: 11587485